Alterations in nigrostriatal dopaminergic function within BDNF mutant mice

Experimental Neurology

Volumn 160, Issue 2, 1999, Pages 500-507

  Dluzen, Dean E ^a   Story, Gina M ^a   Xu, Kui ^a   Kucera, Jan ^b   Walro, Jon M ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain derived neurotrophic factor; Corpus striatum; Dopamine; Hypothalamus; Nigrostriatal; Norepinephrine; Olfactory bulb

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOLAMINE; DOPAMINE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE DEPLETION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; FEMALE; GENE INACTIVATION; GENE MUTATION; GENE TARGETING; HETEROZYGOSITY; HYPOTHALAMUS; MALE; MOUSE MUTANT; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL;

EID: 0032763829     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7225     Document Type: Article

References (40)

1. Aliaga E., Rage F., Bustos G., Tapia-Arancibia L. BDNF gene transcripts in mesencephalic neurons and its differential regulation by NMDA. NeuroReport. 9:1998;1959-1962.
2. Altar C. A., Cai N., Bliven T., Juhasz M., Conner J. M., Acheson A. L., Lindsay R. M., Wiegand S. J. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature. 389:1997;856-860.
3. Beck K. D. Functions of brain-derived neurotrophic factor, insulin-like growth factor and basic fibroblast growth factor in the development and maintenance of dopaminergic neurons. Prog. Neurobiol. 44:1994;497-516.
4. Beck K. D., Knusel B., Hefti F. The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1 and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture. Neuroscience. 52:1993;855-866.
5. Bianchi L. M., Conover J. C., Fritzsch B., DeChiara T., Lindsay R. M., Yancopoulos G. D. Degeneration of vestibular neurons in late embryogenesis of both heterozygous and homozygous BDNF null mutant mice. Development. 122:1996;1965-1973.
6. Lntr receptors. J. Biol. Chem. 271:1996;21100-21107.
7. Chiueh C. C., Maiyake H., Peng M. T. Role of dopamine autoxidation, hydroxyl radical generation and calcium overload in underlying mechanisms in MPTP-induced Parkinsonism. Adv. Neurol. 60:1993;251-258.
8. Chiueh C. C., Wu R.-M., Mohanuakumar K. P., Sternberger L. M., Krishna G., Obata T., Murphy D. L. In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia. Ann. N.Y. Acad. Sci. 738:1994;25-36.
9. Conner J. M., Lanterborn J. C., Yan Q., Gall C. M., Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in normal adult rat CNS: Evidence for anterograde axonal transport. J. Neurosci. 17:1997;2295-2313.
10. Conover J. C., Erickson J. T., Katz D. M., Bianchi L. M., Poueymirou W. T., McLain J., Pan L., Helgren M., Ip N. Y., Doland P., Friedman B., Wiegand S., Vejsada R., Kato A. C., DeChiara T. M., Yancopoulos G. D. Neuronal deficits, not involving motor neurons, in mice lacking BDNF and/or NT4. Nature. 375:1995;235-237.
11. Conover J. C., Yancopoulos G. D. Neurotrophin regulation of the developing nervous system: Analysis of knockout mice. Rev. Neurosci. 8:1997;13-27.
12. Croll S. D., Ip N. Y., Lindsay R. M., Wiegand S. J. Expression of BDNF and trkB as a function of age and cognitive performance. Brain Res. 812:1998;200-208.
13. Dluzen D. E. Age-related changes in monoamines within the olfactory bulbs of the Fischer 344 male rat. Mech. Ageing Develop. 91:1996;37-45.
14. Dluzen D. E., Liu B., Chen C.-Y., DiCarlo S. E. Daily spontaneous running alters behavioral and neurochemical indices of nigrostriatal function. J. Appl. Physiol. 78:1995;1219-1224.
15. Ernfors P., Lee K-F., Jaenisch R. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature. 363:1994;147-150.
16. Felten D. L., Felten S. Y., Steece-Collier K., Date I., Clemens J. A. Age related decline in the dopaminergic nigrostriatal system: The oxidative hypothesis and protective strategies. Ann. Neurol. Suppl. 32:1992;S133-S136.
17. Filloux F., Townsend J. J. Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp. Neurol. 119:1993;79-88.
18. Friedman W. J., Ernfors P., Persson H. Transient and persistent expression of NT-3/HDNF mRNA in the rat brain during postnatal development. J. Neurosci. 11:1991;1577-1584.
19. Hofer M., Pagliusi S. R., Hohn A., Leibrock J., Barde Y-A. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J. 9:1990;2459-2464.
20. Hoglinger G. U., Sautter J., Meyer M., Spenger C., Seiler R. W., Oertel W. H., Widmer H. R. Rat fetal mesencephalon grown as solid tissue cultures: Influence of culture time and BDNF treatment on dopamine neuron survival and function. Brain Res. 813:1998;313-322.
21. Hyman C., Hofer M., Barde Y-A., Juhasz M., Yancopoulos G. D., Squinto S. P., Lindsay R. M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 350:1991;230-232.
22. Hyman C., Juhasz M., Jackson C., Wright P., Ip N. Y., Lindsay R. M. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14:1994;335-347.
23. Jones K. R., Farinas I., Backus C., Reichardt L. F. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell. 76:1994;989-999.
24. Katoh-Semba R., Semba R., Takeuchi I. K., Kato K. Age related changes in levels of brain-derived neurotrophic factor in selected brain regions of rats, normal mice and senescence-accelerated mice: A comparison to those of nerve growth factor and neurotrophin-3. Neurosci. Res. 31:1998;227-234.
25. Knusel B., Winslow J. W., Rosenthal A., Burton L. E., Seid D. P., Nikolics K., Hefti F. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc. Natl. Acad. Sci. USA. 88:1991;961-965.
26. Lindsay R. M., Altar C. A., Cedarbaum J. M., Hyman C., Wiegand S. J. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease. Exp. Neurol. 124:1993;103-118.
27. Liu X., Ernfors P., Wu H., Jaenisch R. Sensory but not motor neuron deficits in mice lacking NT4 and BDNF. Nature. 375:1995;238-241.
28. Liu Y., Peter D., Roghani A., Schuldiner S., Prive G. G., Eisenberg D., Brecha N., Edwards R. H. A cDNA that suppresses MPP + toxicity encodes a vesicular amine transporter. Cell. 70:1992;539-551.
29. Loudes C., Petit F., Kordon C., Faivre-Bauman A. Distinct populations of hypothalamic dopaminergic neurons exhibit differential responses to brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT3). Eur. J. Neurosci. 11:1999;617-624.
30. Maisonpierre P. C., Belluscio L., Friedman B., Alderson R. F., Wiegand S. J., Furth M. E., Lindsay R. M., Yancopoulos G. D. NT-3, BDNF, and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression. Neuron. 5:1990;501-509.
31. McLean J. H., Shipley M. T., Nickell W. T., Aston-Jones G., Reyher C. K. Chemoanatomical organization of the noradrenergic input from locus coeruleus to the olfactory bulb of the adult rat. J. Comp. Neurol. 285:1989;339-349.
32. Michel P. P., Hefti F. Toxicity of 6-hydroxydopamine for dopaminergic neurons in culture. J. Neurosci. Res. 26:1990;428-435.
33. Olanow C. W. A scientific rationale for protective therapy in Parkinson's disease. J. Neural Transm. 91:1993;161-180.
34. Okazawa H., Murata M., Watanabe M., Kamei M., Kanazawa I. Dopaminergic stimulation up-regulates the in vivo expression of brain-derived neurotrophic factor (BDNF) in the striatum. FEBS Lett. 313:1992;138-142.
35. Sautter J., Meyer M., Spenger C., Seiler R. W., Widmer H. R. Effects of combined BDNF and GDNF treatment on cultured dopaminergic midbrain neurons. NeuroReport. 9:1998;1093-1096.
36. Shipley M. T., Halloran F. J., de la Torre J. Surprisingly rich projection from locus coeruleus to the olfactory bulb in the rat. Brain Res. 329:1985;294-299.
37. Skaper S. D., Negro A., Facci L., Dal Toso R. Brain derived neurotrophic factor selectively rescues mesencephalic dopaminergic neurons from 2,4,5-trihydroxyphenylalanine-induced injury. J. Neurosci. Res. 34:1993;478-487.
38. Spenger C., Hyman C., Studer L., Egli M., Evtouchenko L., Jackson C., Dahl-Jorgensen A., Lindsay R. M., Seiler R. W. Effects of BDNF on dopaminergic, serotonergic and GABAergic neurons in cultures of fetal ventral mesencephalon. Exp. Neurol. 133:1995;50-63.
39. Spina M. B., Squinto S. P., Miller J., Lindsay R. M., Hyman C. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: Involvement of the glutathione system. J. Neurochem. 59:1992;99-106.
40. Zhou J., Bradford H. F., Stern G. M. The response of human and rat fetal mesencephalon in culture to the brain-derived neurotrophic factor treatment. Brain Res. 656:1994;147-156.